The scent of COVID-19: viral (semi-) volatiles as fast diagnostic biomarkers? K Lamote, E Janssens, E Schillebeedat, TS Lapperre, BY De Winter, ... Journal of breath research.-Bristol, 2007, currens 14 (4), 042001, 2020 | 74 | 2020 |
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study K Lamote, P Brinkman, L Vandermeersch, M Vynck, PJ Sterk, ... Oncotarget 8 (53), 91593, 2017 | 61 | 2017 |
Volatile organic compounds in human matrices as lung cancer biomarkers: A systematic review E Janssens, JP van Meerbeeck, K Lamote Critical Reviews in Oncology/Hematology 153, 103037, 2020 | 59 | 2020 |
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot? S Lagniau, K Lamote, JP van Meerbeeck, KY Vermaelen Oncotarget 8 (32), 53751, 2017 | 51 | 2017 |
Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review L Brusselmans, L Arnouts, C Millevert, J Vandersnickt, JP van Meerbeeck, ... Translational lung cancer research 7 (5), 520, 2018 | 39 | 2018 |
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: A systematic review and meta-analysis E Schillebeeckx, JP van Meerbeeck, K Lamote European Respiratory Review 30 (162), 2021 | 33 | 2021 |
Exhaled breath to screen for malignant pleural mesothelioma: a validation study K Lamote, M Vynck, O Thas, J Van Cleemput, K Nackaerts, ... European Respiratory Journal 50 (6), 2017 | 30 | 2017 |
A literature review of the potential diagnostic biomarkers of head and neck neoplasms H Konings, S Stappers, M Geens, BY De Winter, K Lamote, ... Frontiers in oncology 10, 1020, 2020 | 29 | 2020 |
Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS) K Lamote, M Vynck, J Van Cleemput, O Thas, K Nackaerts, ... Journal of Breath Research 10 (4), 046001, 2016 | 29 | 2016 |
Volatomics in inflammatory bowel disease and irritable bowel syndrome K Van Malderen, BY De Winter, G Joris, HU De Schepper, K Lamote EBioMedicine 54, 2020 | 27 | 2020 |
A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity A Smet, T Breugelmans, J Michiels, K Lamote, W Arras, G Joris, ... JCI insight 6 (19), 2021 | 23 | 2021 |
The electronic nose: emerging biomarkers in lung cancer diagnostics WH van Geffen, K Lamote, A Costantini, LEL Hendriks, NM Rahman, ... Breathe 15 (4), e135-e141, 2019 | 22 | 2019 |
Strengths, Weaknesses, and Opportunities of Diagnostic Breathomics in Pleural Mesothelioma—A Hypothesis K Lamote, K Nackaerts, JP van Meerbeeck Cancer Epidemiology Biomarkers & Prevention 23 (6), 898-908, 2014 | 20 | 2014 |
Fibulin-3 as a biomarker for pleural mesothelioma. K Lamote, P Baas, van Meerbeeck J.P. The New England journal of medicine. 368 (2), 189-190, 2013 | 19* | 2013 |
DNA methylation as a diagnostic biomarker for malignant mesothelioma: a systematic review and meta-analysis J Vandenhoeck, JP van Meerbeeck, E Fransen, J Raskin, G Van Camp, ... Journal of Thoracic Oncology 16 (9), 1461-1478, 2021 | 12 | 2021 |
Calcium phosphate cements modified with pore expanded SBA-15 materials NMF Van den Vreken, E De Canck, M Ide, K Lamote, P Van Der Voort, ... Journal of Materials Chemistry 22 (29), 14502-14509, 2012 | 10 | 2012 |
Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study K Van Malderen, N Hanning, H Lambrechts, T Haverhals, S Van Marcke, ... Frontiers in Medicine 9, 960000, 2022 | 6 | 2022 |
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients E Janssens, K Lamote, J Van Meerbeeck, L Brusselmans European Respiratory Journal 52 (suppl 62), 2018 | 6 | 2018 |
Expression of SARS-CoV-2-related surface proteins in non-small-cell lung cancer patients and the influence of standard of care therapy C Deben, M Le Compte, V Siozopoulou, H Lambrechts, C Hermans, ... Cancers 14 (17), 4074, 2022 | 5 | 2022 |
Headspace volatile organic compound profiling of pleural mesothelioma and lung cancer cell lines as translational bridge for breath research E Janssens, Z Mol, L Vandermeersch, S Lagniau, KY Vermaelen, ... Frontiers in Oncology 12, 851785, 2022 | 4 | 2022 |